On Tuesday, Roivant Sciences Ltd (NASDAQ: ROIV) opened lower -1.06% from the last session, before settling in for the closing price of $12.22. Price fluctuations for ROIV have ranged from $9.69 to $13.06 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 493.24% annually for the last half of the decade. Company’s average yearly earnings per share was noted -113.50% at the time writing. With a float of $380.88 million, this company’s outstanding shares have now reached $733.33 million.
In an organization with 908 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 88.77%, operating margin of 3447.71%, and the pretax margin is 3781.64%.
Roivant Sciences Ltd (ROIV) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Roivant Sciences Ltd is 47.68%, while institutional ownership is 67.73%. The most recent insider transaction that took place on Nov 20 ’24, was worth 1,132,000. In this transaction President & COO of this company sold 100,000 shares at a rate of $11.32, taking the stock ownership to the 606,525 shares. Before that another transaction happened on Nov 20 ’24, when Company’s Officer proposed sale 100,000 for $11.32, making the entire transaction worth $1,132,008.
Roivant Sciences Ltd (ROIV) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.21 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -113.50% per share during the next fiscal year.
Roivant Sciences Ltd (NASDAQ: ROIV) Trading Performance Indicators
Check out the current performance indicators for Roivant Sciences Ltd (ROIV). In the past quarter, the stock posted a quick ratio of 10.43. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 70.03.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 5.66, a number that is poised to hit -0.22 in the next quarter and is forecasted to reach -1.06 in one year’s time.
Technical Analysis of Roivant Sciences Ltd (ROIV)
Let’s dig in a bit further. During the last 5-days, its volume was 4.03 million. That was inferior than the volume of 5.78 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 29.49%. Additionally, its Average True Range was 0.32.
During the past 100 days, Roivant Sciences Ltd’s (ROIV) raw stochastic average was set at 68.41%, which indicates a significant increase from 50.29% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 34.07% in the past 14 days, which was higher than the 27.99% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $11.82, while its 200-day Moving Average is $11.28. However, in the short run, Roivant Sciences Ltd’s stock first resistance to watch stands at $12.24. Second resistance stands at $12.40. The third major resistance level sits at $12.49. If the price goes on to break the first support level at $11.99, it is likely to go to the next support level at $11.90. The third support level lies at $11.74 if the price breaches the second support level.
Roivant Sciences Ltd (NASDAQ: ROIV) Key Stats
There are currently 727,950K shares outstanding in the company with a market cap of 8.80 billion. Presently, the company’s annual sales total 124,800 K according to its annual income of 4,349 M. Last quarter, the company’s sales amounted to 4,480 K and its income totaled -230,180 K.
